Credit Suisse

China Vanke Co rode the positive momentum that followed the truce in the China and US trade war, raising $630m after an aggressive tightening in price. But the movements in the US Treasury market, including a curve inversion between three and five year notes, hit the secondary performance of the company’s bond.

Tencent Music Entertainment Group has begun bookbuilding for its long-awaited $1.23bn IPO in the US, around two months after first gauging investor appetite.

iDreamSky Technology Holdings has pocketed HK$838m ($107.1m) after pricing its IPO just below the mid-point of guidance, according to a banker close to the deal.

Chinese brokerage Huatai Securities has won approval from the Mainland regulator to list Global Depository Receipts (GDRs) in London through the connect scheme with Shanghai.

Three Chinese borrowers with education businesses are seeking funds from retail lenders in syndication.

Four borrowers piled into the dollar bond market on Thursday, adding to one of the busiest weeks of the year despite tough market conditions. UK telecoms company BT led the charge with a $1.35bn two-part deal.

Shanghai Junshi Biosciences kicked off pre-deal investor education for its Hong Kong listing this week, following close behind Chinese telecommunications software provider AsiaInfo Technologies.

WuXi AppTec’s Hong Kong IPO is set to be yet another test case of investor appetite for biotechnology names, as the company kicked off its chunky HK$7.5bn ($958m) flotation this week. With all eyes on the offering, its performance in both primary and secondary can have ramifications for other listing hopefuls in the city, writes Christie Ou.

Edgar Madinaveitia, a managing director in Latin American debt capital markets at Credit Suisse, has left the bank, according to sources away from the bank.

Shanghai Junshi Biosciences has kicked off pre-deal investor education for its Hong Kong listing.

Belgian chemicals manufacturer Solvay sold its first public corporate bonds for three years on Tuesday when it reopened the European hybrid bond market, which has not seen a new issue since September. Despite the recent dearth of issuance, the market is still set to record an increase of more than 57% on 2017’s total volume.

Mumbai-headquartered Metropolis Healthcare has been given the go ahead to list by the Securities and Exchange Board of India, paving the way for an equity sale by two shareholders.